Medifast
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
THOMAS ANDREA B director
Common Stock 50 $68.89 $3,445
Purchase
HOER MICHAEL A. director
Common Stock 49 $68.89 $3,376
Purchase
SCHLACKMAN SCOTT director
Common Stock 52 $68.89 $3,582
Purchase
BROWN JEFFREY J director
Common Stock 58 $68.89 $3,996
Purchase
XIAN MING director
Restricted Stock Units (cash settled) 48 N/A N/A
Purchase
BROWN JEFFREY J director
Common Stock 96 $70.55 $6,773
Sale
HALLQUIST CONSTANCE J.
Common Stock 5,613 $73.87 $414,632
Sale
BROWN JEFFREY J director
Common Stock 9,832 $89.79 $882,815
Sale
BROWN JEFFREY J director
Common Stock 13,330 $90.47 $1,205,965
Sale
BROWN JEFFREY J director
Common Stock 15,154 $92.6 $1,403,260
Purchase
BROWN JEFFREY J director
Common Stock 44 $89.42 $3,934
Purchase
SCHLACKMAN SCOTT director
Common Stock 39 $89.42 $3,487
Purchase
THOMAS ANDREA B director
Common Stock 38 $89.42 $3,398
Purchase
XIAN MING director
Restricted Stock Units (cash settled) 36 N/A N/A
Purchase
HOER MICHAEL A. director
Common Stock 37 $89.42 $3,309
Purchase
BROWN JEFFREY J director
Common Stock 621 $100.03 $62,119
Purchase
BROWN JEFFREY J director
Common Stock 67 $100.03 $6,702
Option
MALONEY JAMES P. officer: Chief Financial Officer
Common Stock 3,574 N/A N/A
Purchase
BROWN JEFFREY J director
Common Stock 15 $87.5 $1,313
Purchase
HOER MICHAEL A. director
Common Stock 12 $87.5 $1,050
Purchase
HALLQUIST CONSTANCE J. director
Common Stock 13 $87.5 $1,138
Purchase
SCHLACKMAN SCOTT director
Common Stock 13 $87.5 $1,138
Purchase
XIAN MING director
Restricted Stock Units (cash settled) 12 N/A N/A
Purchase
THOMAS ANDREA B director
Common Stock 12 $87.5 $1,050
Purchase
BROWN JEFFREY J director
Common Stock 680 $89.74 $61,023
Purchase
BROWN JEFFREY J director
Common Stock 73 $89.74 $6,551
Option
SCHLACKMAN SCOTT director
Stock Option (Right to Buy) 2,200 $27.68 $60,896
Sale
SCHLACKMAN SCOTT director
Common Stock 2,200 $108.68 $239,096
Option
SCHLACKMAN SCOTT director
Common Stock 2,200 $27.68 $60,896
Purchase
HALLQUIST CONSTANCE J. director
Common Stock 9 $114.97 $1,035
Purchase
SCHLACKMAN SCOTT director
Common Stock 9 $114.97 $1,035
Purchase
THOMAS ANDREA B director
Common Stock 9 $114.97 $1,035
Purchase
HOER MICHAEL A. director
Common Stock 9 $114.97 $1,035
Purchase
BROWN JEFFREY J director
Common Stock 11 $114.97 $1,265
Purchase
BROWN JEFFREY J director
Common Stock 55 $116.11 $6,386
Purchase
BROWN JEFFREY J director
Common Stock 515 $116.11 $59,797
Purchase
BROWN JEFFREY J director
Common Stock 11 $106.93 $1,176
Purchase
HALLQUIST CONSTANCE J. director
Common Stock 10 $106.93 $1,069
Purchase
HOER MICHAEL A. director
Common Stock 10 $106.93 $1,069
Purchase
SCHLACKMAN SCOTT director
Common Stock 10 $106.93 $1,069
Purchase
THOMAS ANDREA B director
Common Stock 10 $106.93 $1,069
Purchase
BROWN JEFFREY J director
Common Stock 560 $105.06 $58,834
Purchase
BROWN JEFFREY J director
Common Stock 3,530 $126.63 $447,004
Purchase
BROWN JEFFREY J director
Common Stock 410 $125.72 $51,545
Purchase
BROWN JEFFREY J director
Common Stock 399 $146.01 $58,260
Purchase
CHARD DANIEL R director, officer: Chairman & CEO
Common Stock 431 $183.25 $78,981
Purchase
BROWN JEFFREY J director
Common Stock 315 $183.25 $57,724
Sale
THOMAS ANDREA B director
Common Stock 1,150 $174.31 $200,457
Option
CHARD DANIEL R director, officer: Chairman & CEO
Common Stock 24,072 N/A N/A
Option
BYRNES KEVIN G director
Stock Options 5,000 $27.68 $138,400

Showing 1 to 50 of 284 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.